NovoCure Limited

Historical 13F Holders

Symbol
NVCR
CUSIP
G6674U108
All holders as of
Q1 2025
Type
Equity
Class
ORD SHS
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 239 95.2 M $1.70 B
2024 Q4 268 91.7 M $2.73 B
2024 Q3 242 93.3 M $1.46 B
2024 Q2 258 93.9 M $1.61 B
2024 Q1 266 92.9 M $1.46 B
2023 Q4 250 92.4 M $1.38 B
2023 Q3 259 92.3 M $1.49 B
2023 Q2 298 90.8 M $3.78 B
2023 Q1 329 89.6 M $5.38 B
2022 Q4 352 87.2 M $6.40 B
2022 Q3 333 83.7 M $6.36 B
2022 Q2 345 80.7 M $5.65 B
2022 Q1 341 81.7 M $6.81 B
2021 Q4 355 79.2 M $5.94 B
2021 Q3 355 77.6 M $9.01 B
2021 Q2 398 77.7 M $17.2 B
2021 Q1 362 75.3 M $9.95 B
2020 Q4 399 74.8 M $13.0 B
2020 Q3 321 73.3 M $8.16 B
2020 Q2 301 69.2 M $4.10 B
2020 Q1 312 70.6 M $4.75 B
2019 Q4 293 70.2 M $5.90 B
2019 Q3 273 66.9 M $5.00 B
2019 Q2 228 68.8 M $4.35 B
2019 Q1 216 63.6 M $3.06 B
2018 Q4 180 57.8 M $1.94 B
2018 Q3 198 56.2 M $2.94 B
2018 Q2 178 52.1 M $1.63 B
2018 Q1 142 44.1 M $962 M
2017 Q4 138 37.4 M $756 M
2017 Q3 116 36.8 M $731 M
2017 Q2 94 31.9 M $552 M
2017 Q1 79 20.3 M $165 M
2016 Q4 85 20.5 M $161 M
2016 Q3 72 19.6 M $167 M
2016 Q2 75 19.5 M $228 M
2016 Q1 67 13.6 M $197 M
2015 Q4 55 11.7 M $257 M